Teemsun(301571)

Search documents
国科天成8.8亿可转债获受理,加速布局四核心项目
IPO日报· 2025-08-02 02:03
星标 ★ IPO日报 精彩文章第一时间推送 AI制图 红外光电技术正在多个领域加速渗透。红外成像、激光雷达、智能感知等技术在防务、工业、消费电子等行业得到广泛应用。 近期,深交所创业板上市委正式受理了国科天成科技股份有限公司(301571.SZ,下称"国科天成")的可转债发行申请。 这家去年8月才登陆资本市场的红外光电技术企业,在上市不足一年之际,再次向市场抛出总额不超过8.8亿元的再融资计划。 根据公告,本次可转债发行总额不超过8.8亿元,债券期限六年,票面利率将由公司与保荐机构根据市场状况协商确定。 资料显示,国科天成自成立以来,专注于红外光电技术的研发与应用,产品广泛应用于防务、工业检测、消费电子等多个领域。 结合财务数据来看,公司业绩近年来呈现快速发展的态势。 2022年至2024年,公司实现营业收入分别为5.30亿元、7.02亿元、9.61亿元,呈现持续上升趋势;同期,归母净利润分别为0.97亿元、1.27亿元、1.73亿 元。 制图:李昕 文字编辑 褚念颖 根据草案,本次募集资金拟投向五个部分,分别为非制冷红外探测器建设项目、超精密长波红外镜头产线建设项目、近红外APD光电探测器产线建设项 目、中 ...
国科天成: 6-1 发行人最近三年的财务报告及其审计报告以及最近一期的财务报告
Zheng Quan Zhi Xing· 2025-07-25 16:14
国科天成科技股份有限公司 财务报表附注 财务报表附注 公司基本情况 国科天成科技股份有限公司(以下简称"本公司"或"公司")前身为国科天成(北京) 科技有限公司(以下简称"有限公司"),有限公司由罗珏典、吴明星和刘怀英共同出资 设立,于 2014 年 1 月 8 日经北京市工商行政管理局批准成立并核发企业法人营业执照。 有限公司设立时注册资本 100 万元,设立时出资额及占比如下: 股东名称 出资额(万元) 出资比例(%) 出资方式 罗珏典 40.00 40.00 货币 吴明星 30.00 30.00 货币 刘怀英 30.00 30.00 货币 合计 100.00 100.00 吴明星、刘怀英分别将其持有公司的 12%、9%、9%的股权以原出资额转让给北京空应科 技发展有限公司(以下简称"空应科技"),并于 2014 年 7 月 8 日办理了工商变更登记。 本次股权转让后各股东出资情况如下: 股东名称 出资额(万元) 出资比例(%) 出资方式 空应科技 30.00 30.00 货币 罗珏典 28.00 28.00 货币 吴明星 21.00 21.00 货币 刘怀英 21.00 21.00 货币 合计 100. ...
国科天成: 3-1 证券发行保荐书
Zheng Quan Zhi Xing· 2025-07-25 16:14
Core Viewpoint - Guoke Tianceng Technology Co., Ltd. plans to issue convertible bonds not exceeding 880 million yuan to unspecified investors, with Guotai Junan Securities Co., Ltd. as the sponsor for this issuance [1][2]. Group 1: Issuance Details - The issuance amount is set at a maximum of 880 million yuan [1]. - The sponsor for this issuance is Guotai Junan Securities Co., Ltd. [2]. - The designated representatives for the issuance are Xu Yu and Chen Libin, both with extensive experience in investment banking [2][3]. Group 2: Company Overview - Guoke Tianceng Technology Co., Ltd. is listed on the Shenzhen Stock Exchange under the stock code 301571.SZ [4]. - The company specializes in the research, production, and sales of optoelectronic products, navigation products, and remote sensing data products [5]. - As of March 31, 2025, the company has a total share capital of 17,942.59 million shares, with 80% being restricted shares and 20% being freely tradable shares [5]. Group 3: Financial Performance - The company's revenue for the first quarter of 2025 was 11,969.47 million yuan, showing a significant increase compared to previous years [6][11]. - The main business revenue composition includes optoelectronic business (87.56%), navigation business (5.19%), information systems (0.68%), and remote sensing (6.57%) [6][7]. - The company has achieved a total of 44 invention patents, 14 utility model patents, and 22 design patents, indicating a strong focus on technological innovation [5][6]. Group 4: Shareholder Structure - As of March 31, 2025, the top ten shareholders hold a combined 51.58% of the company's shares, with no pledges or freezes on these shares [5]. - The controlling shareholders are Luo Juedian and Wu Mingxing, who collectively hold 28.97% of the voting rights [9].
国科天成: 4-1 法律意见书
Zheng Quan Zhi Xing· 2025-07-25 16:14
Core Viewpoint - The legal opinion letter issued by Beijing King & Wood Mallesons (Chengdu) Law Firm confirms the compliance of Guoke Tianceng Technology Co., Ltd. with the regulations for issuing convertible bonds to unspecified objects, detailing the necessary legal frameworks and procedures involved in the issuance [1][2][4]. Group 1: Legal Framework and Compliance - The law firm conducted its analysis based on various Chinese laws and regulations, including the Securities Law and Company Law, ensuring adherence to the legal standards required for the issuance of convertible bonds [2][3]. - The firm verified the authenticity and completeness of the documents provided by the issuer, ensuring that all materials were accurate and legally compliant [2][3]. Group 2: Issuance Details - The total amount of the convertible bonds to be issued is capped at RMB 880 million, with each bond having a face value of RMB 100 [12][13]. - The bonds will have a maturity period of six years, with interest paid annually, and the specific interest rate will be determined based on market conditions and company performance [13][14]. - The conversion period for the bonds will commence six months after issuance and will last until the maturity date [14][17]. Group 3: Conversion and Redemption Terms - The initial conversion price will be set based on the average trading price of the company's A-shares over the twenty trading days prior to the announcement, with provisions for adjustments in case of stock changes [15][16]. - The company reserves the right to redeem the bonds at face value plus accrued interest under certain conditions, such as when the stock price exceeds 130% of the conversion price for a specified period [19][19]. - Holders of the convertible bonds have the right to sell back their bonds to the company if the stock price falls below 70% of the conversion price during the last two interest years [19].
国科天成: 1-1 募集说明书(申报稿)(豁免版)
Zheng Quan Zhi Xing· 2025-07-25 16:14
Group 1 - The company, Guoke Tianceng Technology Co., Ltd., is issuing convertible bonds to raise funds for enhancing its core competitiveness and profitability in the infrared optoelectronic industry [10][11][12] - The total amount of the convertible bonds to be issued is not more than RMB 880 million, with each bond having a face value of RMB 100 [15][16] - The funds raised will be allocated to projects including the construction of non-refrigerated infrared detectors, near-infrared APD photodetector production lines, and mid-wave infrared semiconductor laser projects [16] Group 2 - The infrared optoelectronic industry is supported by national policies, with increasing applications in both defense and civilian sectors, leading to a growing market demand [10][11][12] - The company has established a strong market position in the infrared field, focusing on both refrigerated and non-refrigerated infrared detectors, and is expanding its production capacity to meet the rising demand [12][13] - The company aims to enhance its product structure and profitability by developing new products such as near-infrared APD photodetectors and mid-wave infrared semiconductor lasers [13][14]
国科天成: 3-3 上市保荐书
Zheng Quan Zhi Xing· 2025-07-25 16:14
Core Viewpoint - The company, Teemsun Technology Co., Ltd., is planning to issue convertible bonds to unspecified investors, aiming to raise up to RMB 880 million to enhance its production capacity and improve its core component supply capabilities [15][23]. Company Overview - Teemsun Technology Co., Ltd. specializes in the research, production, and sales of optoelectronic products, particularly in infrared thermal imaging, navigation, and remote sensing [4][3]. - The company has obtained a total of 80 patents, including 44 invention patents, 14 utility model patents, and 22 design patents, showcasing its commitment to technological innovation [4]. Financial Data - As of the end of 2024, the total assets of the company amounted to RMB 2.5198 billion, with total liabilities of RMB 671.26 million, resulting in total equity of RMB 1.8485 billion [5]. - The company reported a revenue of RMB 960.65 million for the year 2024, with a net profit of RMB 175.43 million, reflecting a significant increase from RMB 121.42 million in 2023 [5][6]. Business Risks - The company faces risks related to macroeconomic changes, particularly in the defense sector, which could impact demand for its products [8]. - There is a risk of technological obsolescence in the optoelectronic industry, necessitating continuous investment in research and development [8]. - The company is also exposed to risks associated with the production capacity of its self-developed T2SL detectors, which are still in the ramp-up phase [8]. Issuance Details - The convertible bonds will have a face value of RMB 100 each and a maturity period of six years [15]. - The issuance will prioritize existing shareholders, with any remaining bonds offered to institutional investors [15][24]. Management and Oversight - The underwriting and advisory roles are being handled by Guotai Junan Securities, with a commitment to adhere to regulatory standards and ensure the integrity of the issuance process [18][21].
7月25日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-25 11:30
Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]
国科天成:向不特定对象发行可转换公司债券申请获受理
news flash· 2025-07-25 03:54
国科天成(301571)公告,公司于2025年7月24日收到深圳证券交易所出具的《关于受理国科天成科技 股份有限公司向不特定对象发行可转换公司债券申请文件的通知》。深交所对公司报送的向不特定对象 发行可转换公司债券的申请文件进行了核对,认为申请文件齐备,决定予以受理。本次发行尚需深交所 审核,并获得中国证券监督管理委员会作出同意注册的决定后方可实施。公司将根据该事项的进展情 况,按照相关法律法规规定和要求及时履行信息披露义务。 ...
国科天成(301571) - 关于向不特定对象发行可转换公司债券申请获得深圳证券交易所受理的公告
2025-07-25 03:49
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没 有虚假记载、误导性陈述或重大遗漏。 证券代码:301571 证券简称:国科天成 公告编号:2025-042 国科天成科技股份有限公司 关于向不特定对象发行可转换公司债券申请获得深圳证券 交易所受理的公告 国科天成科技股份有限公司董事会 2025 年 7 月 25 日 国科天成科技股份有限公司(以下简称"公司")于 2025 年 7 月 24 日收到深圳证券交易所(以下简称"深交所")出具的《关于受理国 科天成科技股份有限公司向不特定对象发行可转换公司债券申请文 件的通知》(深证上审(2025)143 号)。深交所对公司报送的向不特定 对象发行可转换公司债券的申请文件进行了核对,认为申请文件齐备, 决定予以受理。 公司本次向不特定对象发行可转换公司债券事项尚需深交所审 核,并获得中国证券监督管理委员会(以下简称"证监会")作出同意 注册的决定后方可实施。公司本次向不特定对象发行可转换公司债券 的事项最终能否通过深交所审核并获得证监会作出同意注册的批复 及其时间尚存在不确定性。公司将根据该事项的进展情况,按照相关 法律法规规定和要求及时履行信息披露义务 ...
国科天成(301571) - 4-1 法律意见书
2025-07-25 03:49
北京金杜(成都)律师事务所 关于国科天成科技股份有限公司 向不特定对象发行可转换公司债券 之 法律意见书 致:国科天成科技股份有限公司 北京金杜(成都)律师事务所(以下简称本所)接受国科天成科技股份有限 公司(以下简称发行人)委托,担任发行人本次向不特定对象发行可转换公司债 券(以下简称本次发行)的中国境内专项法律顾问。 本所根据《中华人民共和国证券法》(以下简称《证券法》)、《中华人民 共和国公司法》(以下简称《公司法》)、《上市公司证券发行注册管理办法》 (以下简称《注册管理办法》)《深圳证券交易所创业板股票上市规则》(以下 简称《创业板上市规则》)、《律师事务所从事证券法律业务管理办法》(以下 简称《证券法律业务管理办法》)、《律师事务所证券法律业务执业规则(试 行)》(以下简称《证券法律业务执业规则》)、《公开发行证券公司信息披露 的编报规则第 12 号——公开发行证券的法律意见书和律师工作报告》(以下简称 《编报规则第 12 号》)等中华人民共和国境内(以下简称中国境内,为本法律意 见书之目的,不包括中国香港特别行政区、中国澳门特别行政区和中国台湾省) 现行有效的法律、行政法规、规章和规范性文件和中 ...